Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life.
We work with government authorities to ensure patients have access to care while also funding medical research.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
Every day at CSL Behring, we work as if someone’s life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
Make your well-being a priority. It's important and so are you.
Miss America 2020 won the rebooted contest with an on-stage experiment.
The “Cube” in Marburg will house 600 colleagues upon completion in 2022.
The ingredient that gives leaves and plasma their yellow colors.
Pathogen expert Nathan Roth leads a team that takes a vigilant approach with the medicines patients rely on.
CSL Behring named Penn State University’s Corporate Partner of the Year.
Every Nobel Prize week, we remember CSL Behring’s namesake, named a Nobel laureate in 1901.
A data-driven approach to predicting outbreaks could be good news for at-risk patients.
See our infographic to find out how much data storage scientists need as they pursue medical breakthroughs.
Alistair Grevis-James aims to advance data protection.
Take a tour of Philadelphia's iconic murals, including a new biotech-themed work of art sponsored by CSL Behring.
Replacing C1-INH plasma protein gives a rare disease a longed-for treatment.
The role data science plays in new medicine development.
Popular search terms:
Americas
Asia Pacific
Europe
